Recent trends in the epidemiology of sexually transmitted infections in the European Union

Sexually Transmitted Infections

Volumn 80, Issue 4, 2004, Pages 255-263

  Fenton, K A ^a,b   Lowndes, C M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIOR MODIFICATION; CHLAMYDIASIS; CONDYLOMA; DEMOGRAPHY; DISEASE TRANSMISSION; EUROPEAN UNION; GENITAL HERPES; GONORRHEA; HUMAN; MIGRATION; NORWAY; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SOCIAL BEHAVIOR; SYPHILIS;

EID: 4043167017     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2004.009415     Document Type: Review

References (73)

1. Holmes KK, Sparling PF, Mardh PA, et al. Sexually transmitted diseases. 3rd ed. USA: McGraw-Hill, 1999.
2. Wasserheit J, Aral S. The dynamic topology of sexually transmitted disease epidemics: implication for prevention strategies. J Infect Dis 1996;174:201-13.
3. Van der Heyden JH, Catchpole MA, Paget WJ, Stroobont A, European Study Group. Trends in gonorrhoea in nine western European countries, 1991-6. Sex Transm Infect 2000;76:110-6.
4. Adler M, Meheust A. Epidemiology of sexually transmitted infections and human immunodeficiency virus in Europe. J Eur Acad Dermatol Venereol 2000;14:370-7.
5. Van Duynhoven Y. The epidemiology of Neisseria gonorrhoeae in Europe. Microbes Infect 1999;1:455-64.
6. Panchaud C, Singh S, Feivelson D, et al. Sexually transmitted diseases among adolescents in developed countries. Fam Plann Perspect 2000;32:24-32, 45.
7. Eurostat. Theme: general statistics. Free data. Available at europa.eu.int/comm/eurostat/, last accessed on 15 January 2004. Eurostat, 2004.
8. Stolte G, Dukers NH, de Wit JB, et al. A summary report from Amsterdam: increase in sexually transmitted diseases and risky sexual behaviour among homosexual men in relation to the introduction of new anti-HIV drugs. Euro Surveill 2002;7:19-22.
9. European Commission. The social situation in Europe 2003, in brief. Brussels: European Commission, 2003.
10. Lowndes CM, Fenton KA, and the European Surveillance of Sexually Transmitted Infections (ESSTI) Network. Surveillance Systems for STIs in the European Union: Facing a changing epidemiology. Sex Transm Infect 2004;80:264-71.
11. Chesson HW, Dee TS, Aral SO. AIDS mortality may have contributed to the decline in syphilis rates in the United States in the 1990s. Sex transm Dis 2003;30:419-24.
12. Green MS, Anis E, Gandacu D, et al. The fall and rise of gonorrhoea incidence in Israel: an international phenomenon? Sex Transm Infect 2003;79:116-8.
13. Hiltunen-Back E, Rostila T, Kautiainen H, et al. Rapid decrease of endemic gonorrhea in Finland. Sex Transm Dis 1998;25:181-6.
14. De Schrijver K, Fenton K, Kiehl W, et al. European trends in gonorrhoea. Eurosurveillance Weekly 2000:4.
15. Berglund T, Fredlund H, Giesecke J. Epidemiology of the reemergence of gonorrhea in Sweden. Sex Transm Dis 2001;28:111-14.
16. Berglund T, Fredlund H, Ramstedt K. Reemergence of gonorrhea in Sweden. Sex Transm Dis 1999;26:390-1.
17. Health Protection Agency, SCIEH, ISD, National Public Health Service for Wales, CDSC Northern Ireland, and UASSG. Renewing the focus. HIV and other sexually transmitted infections in the United Kingdom in 2002. London: Health Protection Agency, 1 November 2003.
18. Johansen JD, Smith E. Gonorrhoea in Denmark: high incidence among HIV-infected men who have sex with men. Acta Derm Venereol 2002;82:365-8.
19. Hoffmann S. The laboratory surveillance system of Chlamydia trachomatis and Neisseria gonorrhoeae infections in Denmark. Euro Surveill 2001;6:86-90.
20. Berglund T, Unemo M, Olcen P, et al. One year of Neisseria gonorrhoeae isolates in Sweden: the prevalence study of antibiotic susceptibility shows relation to the geographic area of exposure. Int J STD AIDS 2002;13:109-14.
21. Nicoll A, Hamers FF. Are trends in HIV, gonorrhoea, and syphilis worsening in western Europe? BMJ 2002;324:1324-7.
22. Hiltunen-Back E, Haikala O, Koskela P, et al. Epidemics due to imparted syphilis in Finland. Sex Transm Dis 2002;29:746-51.
23. Doherty L, Fenton KA, Jones J, et al. Syphilis: old problem, new strategy. BMJ 2002;325:153-6.
24. Parkes R, Renton A, Meheus A, et al. Review of current evidence and comparison of guidelines for effective syphilis treatment in Europe. Int J STD AIDS 2004;15:73-88.
25. Pritchard L, Hoile E. Paris syphilis screening campaign extended to selected French towns and cities. Eurosurveillance Weekly 2002:6.
26. Hanquet G. IPH ID team. News on outbreak and infectious diseases. Available at www.lph.fgov.be/epidemio/epien/Issue 19-25 March 2003.
27. Van de Laar MJ, van Veen M, Götz H, et al. Continued transmission of syphilis in Rotterdam, the Netherlands. Eurosurveillance Weekly 2003:7.
28. Axelsen N, Smith E, Koch-Hansen GH. Syphilis cases increasing in Denmark, 2000-01. Eurosurveillance Weekly 2002:6.
29. Petzoldt D, Jappe U, Hartmann M, et al. Sexually transmitted diseases in Germany. Int J STD AIDS 2002;13:246-53.
30. Marcus U, Hamouda O, Kiehl W. Results from laboratory-based reporting of syphilis in Germany, 2001-2002. Eurosurveillance Weekly 2002:6.
31. ESSTI Country STI Surveillance Lead, personal communication, 2003.
32. Johnson AM, Fenton KA, Mercer C. Phase specific strategies for the prevention, control, and elimination of sexually transmitted diseases: background country profile, England and Wales. Sex Trasm Infect 2002;78:i125-i132.
33. Fenton K, Nicoll A, Kinghorn G. Resurgence of syphilis in England: time for more radical and nationally co-ordinated approaches. Sex Transm Infect 2001;77:309-10.
34. Wilson JS, Honey E, Templeton A, et al. A systematic review of the prevalence of Chlamydia trachomatis among European women. Human Reproduction Update 2002;8:385-94.
35. Stary A, Tomazic-Allen S, Choueiri B, et al. Comparison of DNA amplification methods for the detection of Chlamydia trachomatis in first-void urine from asymptomatic military recruits. Sex Transm Dis 1996;23:97-102.
36. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis 2002;186(Suppl 1): S3-28.
37. Kjaer SK, de Villiers EM, Haugaard BJ, et al. Human papillomavirus, herpes simplex virus and cervical cancer incidence in Greenland and Denmark. A population-based cross-sectional study. Int J Cancer 1988;41:518-24.
38. Eskild A, Jeansson S, Jenum PA. [Antibodies against herpes simplex virus type 2 among pregnant women in Norway]. Tidsskr Nor Laegeforen 1999;119:2323-6.
39. Olsen AO, Orstavik I, Dillner J, et al. Herpes simplex virus and human papillomavirus in a population-based case-control study of cervical intraepithelial neoplasia grade II-III. APMIS 1998;106:417-24.
40. Persson K, Mansson A, Jonsson E, et al. Decline of herpes simplex virus type 2 and Chlamydia trachomatis infections from 1970 to 1993 indicated by a similar change in antibody pattern. Scand J Infect Dis 1995;27:195-9.
41. Forsgren M, Skoog E, Jeansson S, et al. Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology. Int J STD AIDS 1994;5:113-6.
42. Arvaja M, Lehtinen M, Koskela P, et al. Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy. Sex Transm Infect 1999;75:168-71.
43. Lehtinen M, Dillner J, Knekt P, et al. Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study. BMJ 1996;312:537-9.
44. Hakama M, Lehtinen M, Knekt P, et al. Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up. Am J Epidemiol 1993;137:166-70.
45. Wutzler P, Doerr HW, Farber I, et al. Seroprevalence of herpes simplex virus type 1 and type 2 in selected German populations - relevance for the incidence of genital herpes. J Med Virol 2000;61:201-7.
46. Gil A, Gonzalez A, Dal-Re R, et al. Prevalence of antibodies against varicella zoster, herpes simplex (types 1 and 2), hepatitis B and hepatitis A viruses among Spanish adolescents. J Infect 1998;36:53-6.
47. Garcia-Corbeira P, Dal-Re R, Aguilar L, et al. Is sexual transmission an important pattern for herpes simplex type 2 virus seroconversion in the Spanish general population? J Med Virol 1999;59:194-7.
48. De Ory F, Pachon I, Echevarria JM, et al. Seroepidemiological study of herpes simplex virus in the female population in the autonomous region of Madrid, Spain. Eur J Clin Microbiol Infect Dis 1999;18:678-80.
49. Pasquini P, Mele A, Franco E, et al. Prevalence of herpes simplex virus type 2 antibodies in selected population groups in Italy. Eur J Clin Microbiol Infect Dis 1988;7:54-6.
50. Franco E, Caprilli F, Zaratti L, et al. Prevalence of antibodies to herpes simplex virus type 1 in different population groups in Italy. Eur J Clin Microbiol 1987;6:322.
51. Jha PK, Beral V, Peto J, et al. Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk. Lancet 1993;341:1116-8.
52. Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988;10:122-63.
53. Roman A, Fife KH. Human papillomaviruses: are we ready to type? Clin Microbiol Rev 1989;2:166-90.
54. Schiffman MA, Brinton LA, Devesa SS, et al. Cervical cancer. In: Schottenfeld D, Fraumeni Jr J, eds. Cancer epidemiology and prevention 1996:1090-116.
55. Burk RD, Kelly P, Feldman J, et al. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 1996;23:333-41.
56. Cuzick J, Szarewski A, Terry G, et al. Human papillomavirus testing in primary cervical screening. Lancet 1995;345:1533-6.
57. Bauer HM, Hildesheim A, Schiffman MH, et al. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 1993;20:274-8.
58. Figueroo JP, Ward E, Luthi TE, et al. Prevalence of human papillomavirus among STD clinic attenders in Jamaica: association of younger age and increased sexual activity. Sex Transm Dis 1995;22:114-8.
59. Karlsson R, Jonsson M, Edlund K, et al. Lifetime number of partners as the only independent risk factor for human papillomavirus infection: a population-based study. Sex Transm Dis 1995;22:119-27.
60. Kenney JW. Risk factors associated with genital HPV infection. Cancer Nurs 1996;19:353-9.
61. Cuzick J, Beverley E, Ho L, et al. HPV testing in primary screening of older women. Br J Cancer 1999;81:554-8.
62. Jamison JH, Kaplan DW, Hamman R, et al. Spectrum of genital human papillomavirus infection in a female adolescent population. Sex Transm Dis 1995;22:236-43.
63. Hippelainen M, Syrjanen S, Koskela H, et al. Prevalence and risk factors of genital human papillomavirus (HPV) infections in healthy males: a study on Finnish conscripts. Sex Transm Dis 1993;20:321-8.
64. Kataoka A, Claesson U, Hansson BG, et al. Human papillomavirus infection of the male diagnosed by Southern-blot hybridization and polymerase chain reaction: comparison between urethra samples and penile biopsy samples. J Med Virol 1991;33:159-64.
65. Grussendorf-Conen El, Meinhof W, de Villiers EM, et al. Occurrence of HPV genomes in penile smears of healthy men. Arch Dermatol Res 1987;279:S73-S75.
66. Johnson AM, Mercer CH, Erens B, et al. Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours. Lancet 2001;358:1835-42.
67. Wellings K, Nanchahal K, Macdowall W, et al. Sexual behaviour in Britain: early heterosexual experience. Lancet 2001;358:1843-50.
68. Dodds J, Nardone A, Mercey D, et al. Increase in high risk sexual behaviour among homosexual men, London 1996-8: cross sectional, questionnaire study. BMJ 2000;320:1510-1.
69. Laporte A. A new decline in preventive behaviours among homosexual men: the role of highly active antiretroviral therapy? Euro Surveill 2002;7:15-6.
70. Department of Health. The national strategy for sexual health and HIV. London: DoH, 2001:1-53.
71. Department of Health. The national strategy for sexual health and HIV: implementation action plan. London: DoH, 2002.
72. All-Party Parliamentary Group on AIDS. Migration and HIV: improving lives in Britain. July 2003. Available at www.appg-aids.org.uk/Publications/ Migration%20and%20HIV%20Improving%20Lives.pdf.
73. World Health Organization. CISID - the Computerized Information System for Infectious Diseases. Geneva: WHO Regional Office for Europe, 2004.